Company Monitoring Page for Mallinckrodt

job ratings (see below graph) for Mallinckrodt

latest headlines for company on cafepharma

Mallinckrodt used 'dirty data' to snow payers on Acthar, whistleblower suit says
Fierce Pharma
Fri, 04/13/18 - 01:14 pm
Tags:
Mallinckrodt, whistleblower lawsuits, H.P. Acthar Gel, fraud
Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis
Fierce Pharma
Thu, 03/1/18 - 11:51 pm
Tags:
Mallinckrodt, oxymorphone, opioid crisis
Mallinckrodt builds pipeline through $1.2B Sucampo deal
Biopharma Dive
Thu, 12/28/17 - 09:20 am
Tags:
Mallinckrodt, Sucampo, M&A
Mallinckrodt continues pipeline revamp with Ocera buy
BioPharma Dive
Sat, 11/4/17 - 08:50 am
Tags:
Mallinckrodt, Ocera Therapeutics, M&A
Mallinckrodt bags another microcap biotech, picking up Ocera’s failed drug in $117M buyout
Endpoints
Thu, 11/2/17 - 09:17 am
Tags:
Mallinckrodt, Ocera Therapeutics, M&A
Mallinckrodt stifled Acthar competition, payer lawsuit claims, clearing path for 85,000% rise in prices
Fierce Pharma
Tue, 10/31/17 - 09:13 pm
Tags:
Mallinckrodt, Acthar, payers, Questcor, drug pricing
Mallinckrodt tumbles after judge invalidates Inomax patents
BioPharma Dive
Wed, 09/6/17 - 08:34 pm
Tags:
Mallinckrodt, Inomax, patents, Praxair
Mallinckrodt beats Q2 earnings, misses on revenue
Drug Delivery Business News
Tue, 08/8/17 - 11:21 pm
Tags:
Mallinckrodt, earnings
Mallinckrodt bags late-stage infantile jaundice drug in $425M InfaCare buyout deal
Endpoints
Mon, 08/7/17 - 11:25 am
Tags:
Mallinckrodt, infantile jaundice, InfaCare, M&A, Stanate
In a critical year for drugmakers, campaign donations, PAC activity are on the rise
Stat
Mon, 07/24/17 - 11:02 am
Tags:
PACs, campaign donations, Mallinckrodt, lobbying
Mallinckrodt Pharmaceuticals is facing scrutiny over the price of its blockbuster drug Acthar
Business Insider
Tue, 06/20/17 - 09:27 am
Tags:
drug pricing, Mallinckrodt, Acthar, PBMs, Express Scripts
3 Biotech Stocks That Could Become M&A Targets
Motley Fool
Sat, 06/17/17 - 03:05 pm
Tags:
biotech, M&A, Mallinckrodt, Tesaro, Incyte
Is Mallinckrodt in Talks to Be Sold?
Motley Fool
Tue, 06/13/17 - 10:14 pm
Tags:
Mallinckrodt, M&A
Instant Analysis: Mallinckrodt Considering Sale of Generics Unit
Motley Fool
Thu, 06/1/17 - 08:48 am
Tags:
Mallinckrodt, generics, M&A
Mallinckrodt exits PhRMA before new rules take hold
BioPharma Dive
Thu, 04/6/17 - 11:56 pm
Tags:
Mallinckrodt, PhRMA, R&D
Mallinckrodt to settle oxycodone diversion case for $35M with Justice Department
Fierce Pharma
Tue, 04/4/17 - 12:24 am
Tags:
Mallinckrodt, DOJ, oxycodone, DEA
Covidien spinout Mallinckrodt closes $690m sale of nuclear imaging biz
Mass Device
Mon, 01/30/17 - 11:53 am
Tags:
Covidien, Mallinckrodt, M&A, nuclear imaging, devices
Martin Shkreli: Mallinckrodt Will Be Punished
Benzinga
Thu, 01/19/17 - 08:35 am
Tags:
Martin Shkreli, Mallinckrodt, Questcor, Daraprim
The Most Expensive Drugs of 2016
Motley Fool
Mon, 12/19/16 - 11:32 am
Tags:
drug pricing, Gilead Sciences, Harvoni, Sovaldi, H.P. Acthar, Mallinckrodt, Shire, Cinryze, Daklinza, Bristol-Myers Squibb
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Motley Fool
Sun, 11/20/16 - 05:33 pm
Tags:
Medicare, H.P. Acthar Gel, Mallinckrodt, Remodulin, United Therapeutics, Tyvaso, Provenge, Valeant Pharmaceuticals, Gilead Sciences, Harvoni

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.